Los Angeles, CA – A philanthropic donation of $10 million from acclaimed entertainer Barbra Streisand in 2012 has significantly advanced specialized cardiac care for women at Cedars-Sinai Medical Center. Fourteen years following its establishment, the Barbra Streisand Women’s Heart Center now provides comprehensive, research-driven treatment to more than 1,700 female patients annually, addressing the distinct cardiovascular health needs of women.

The center's inception was a direct response to recognized disparities and unique challenges in diagnosing and treating heart disease in women. Historically, heart disease research and clinical approaches have often focused on male physiology, leading to gaps in understanding how cardiovascular conditions manifest and progress in women. Symptoms in women can differ from men, frequently resulting in delayed diagnosis or misdiagnosis. The Barbra Streisand Women's Heart Center was conceived to bridge this gap, integrating clinical excellence with a robust research agenda.

Since its founding, the center has developed into a leading institution dedicated to identifying, preventing, and treating heart conditions specific to or disproportionately affecting women. Its multidisciplinary team comprises cardiologists, endocrinologists, geneticists, researchers, and other specialists. This collaborative approach allows for personalized care plans based on individual patient profiles and the latest scientific discoveries. Key areas of focus include:

  • Microvascular Coronary Dysfunction: A condition where small arteries in the heart do not function properly, often overlooked in standard diagnostic tests.
  • Spontaneous Coronary Artery Dissection (SCAD): A tear in a heart artery wall, a significant cause of heart attack in younger women without traditional risk factors.
  • Peripartum Cardiomyopathy: Heart failure occurring during the last month of pregnancy or within five months after childbirth.
  • Heart Disease Prevention: Tailored strategies considering hormonal factors and lifestyle specifics pertinent to women.

The initial $10 million gift from Ms. Streisand was instrumental in establishing the center's foundational infrastructure, funding critical research programs, and recruiting highly specialized medical professionals. This investment enabled the center to rapidly scale its services and deepen its research capabilities. The reported annual patient volume of over 1,700 women underscores the significant demand for such targeted care and the center's successful outreach and impact within the community.

The center's commitment extends beyond direct patient treatment. It actively contributes to global medical knowledge through published research and participation in clinical trials aimed at developing new diagnostic tools and therapies. By translating these findings directly into patient care, the Barbra Streisand Women's Heart Center ensures that women receive advanced, evidence-based treatments tailored to their physiological needs.

Looking ahead, the Barbra Streisand Women's Heart Center is positioned to continue its vital work in advancing women's cardiovascular health. Its ongoing research initiatives are expected to further refine diagnostic criteria and treatment protocols, potentially setting new standards for female cardiac care worldwide. This sustained impact highlights the enduring legacy of philanthropic support in addressing complex health challenges and fostering specialized medical advancements for underserved populations.